House Bill 1716
117th Congress(2021-2022)
COVID–19 Mental Health Research Act
Introduced
Introduced in House on Mar 9, 2021
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1716
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Paul Tonko
grade
New York
Arizona
California
California
California
California
California
California
California
Connecticut
Delaware
District of Columbia
Florida
Georgia
Illinois
Iowa
Kentucky
Maryland
Massachusetts
New Hampshire
New Hampshire
New Jersey
New Jersey
New York
New York
New York
New York
New York
New York
Pennsylvania
Pennsylvania
Washington
Washington
Washington
No House votes have been held for this bill.
Summary
COVID-19 Mental Health Research Act
This bill requires the National Institute of Mental Health to support mental health research activities related to COVID-19 (i.e., coronavirus disease 2019). The institute must coordinate these activities with other components of the National Institutes of Health.
March 9, 2021
03/10/2021
Referred to the Subcommittee on Health.
03/09/2021
Referred to the House Committee on Energy and Commerce.
03/09/2021
Introduced in House
Public Record
Record Updated
Mar 8, 2023 8:12:35 PM